Shanghai ChenGuang Medical Technologies Co., Ltd (hereinafter referred to as: ChenGuang Medical ）was established in 2004,was established in 2004, and has been working on the core components of the whole industry chain of superconducting magnetic resonance (MRI) for nearly 20 years, founded by Dr. Wang Jie, an early research expert in China's MRI industry chain. With independent innovation as the core purpose of development, ChenGuang Medical is an independent innovative high-tech enterprise dedicated to the R&D, production and sales of medical imaging superconducting MRI equipment and special magnets in high-tech cutting-edge fields. It has been selected as one of the "Small Giant" enterprises by the Ministry of Industry and Information Technology of the People's Republic of China in 2022, and one of the "Specialized, Specialized and New" small and medium-sized enterprises in Shanghai.
ChenGuang Medical has achieved the independent development and commercialization of core components for medical MRI systems such as 1.5T, 3.0T and 7.0T. The company's product system covers more than 90% of the hardware of superconducting MRI devices, including: RF detectors, superconducting magnets, gradient coils, RF amplifiers, gradient amplifiers, etc., and can provide specialized and customized one-stop services for global customers. The company's business continues to develop in depth and has obtained the national Class III medical device registration certificate for the 1.5T superconducting MRI system, and the national Class III medical device registration certificate for the 1.48T superconducting MRI system under application has also completed the on-site evaluation. Meanwhile, the 7.0T preclinical MRI system developed by the company has assisted a number of research institutes to achieve key scientific research results and published a number of high-quality SCI papers. Relying on the excellent superconducting magnet technology and design capability. The 230MeV and 250MeV cyclotron superconducting magnets developed by ChenGuang Medical for China Atomic Energy Research Institute became the first compact superconducting cyclotron with proton beam energy reaching 230MeV independently developed in Asia, contributing to the promotion of localization of tumor proton therapy systems. The company further expands the application of special magnets in the field of scientific research. The custom-made special magnets developed independently can cover magnetic field strengths from 0.2T to 11T, and have technologies such as liquid helium-free, ultra-low temperature system manufacturing, superconducting joint design and precision winding and impregnation of superconducting wires, which can meet the scientific research needs for special superconducting magnet applications in many fields in China.
ChenGuang Medical now has 76 patents (including 2 foreign patents and 74 domestic patents), 5 software copyrights and 1 high-tech achievement transformation project; it has passed many authoritative certifications such as CFDA, FDA, CE, PAL, ISO13485, ISO14001, etc. The company has been awarded several times by the Ministry of Science and Technology of China, Shanghai Development and Reform Commission, Shanghai The company has received financial support from the Ministry of Science and Technology of China, Shanghai Development and Reform Commission, Shanghai Municipal Commission of Economy and Information Technology, and Shanghai Science and Technology Commission for many times. With its excellent design capability and long-term accumulated process experience, the company has become one of the few independent third-party suppliers in the world to master the production technology of 1.5T, 3.0T and 7.0T superconducting magnets at the same time, and has established long-term cooperative relationships with domestic and foreign well-known system integrators, universities, research institutes and hospitals.
The company will continue to improve its advanced position in the field of superconducting MRI RF detectors and superconducting magnets, gradually expand the industrial chain and application fields of superconducting MRI, and transform from a component manufacturer to a diversified production and service-oriented enterprise. In the future, with the overall progress of the localization of the industry chain and the integration of resources, ChenGuang Medical will gain a broader market development space and strive to build "ChenGuang Medical" into a Chinese MR brand comparable to international enterprises.
Translated with www.DeepL.com/Translator (free version)
